Dow Up 0.51% Nasdaq Up 0.24%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
50.94 Down 0.68(1.32%) Nov 21, 4:00PM EST
|After Hours : 51.06 Up 0.12 (0.24%) Nov 21, 7:25PM EST
Prev Close:51.62
Open:52.03
Bid:50.50 x 100
Ask:N/A
1y Target Est:49.20
Beta:1.72
Next Earnings Date:N/A
Day's Range:50.75 - 52.58
52wk Range:22.25 - 62.66
Volume:1,531,035
Avg Vol (3m):2,405,900
Market Cap:6.02B
P/E (ttm):N/A
EPS (ttm):-0.81
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ISIS

Comparison

Symbol% ChgMkt Cap
ISISDown 1.32%6.02B
ENZUp 6.92%199.38M
GILDDown 0.01%151.74B
SRPTDown 0.32%649.79M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):35.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.65
Quarterly EPS Est (Dec-14) :-0.06
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-3.45

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback